|
COMMERCE BUSINESS DAILY ISSUE OF APRIL 4,1997 PSA#1817Centers for Disease Control and Prevention, Procurement and Grants
Office, 255 East Paces Ferry Road, NE, Room 500, Atlanta, Georgia
30305 B -- CREUTZFELDT-JAKOB DISEASE SURVEILLANCE IN RECIPIENTS OF HUMAN
GROWTH HORMONE SOL 200-97-0620(p) DUE 051997 POC Barry E. Smith,
Contract Specialist, (404) 842-6787 The Centers for Disease Control and
Prevention (CDC) contemplates awarding a contract to perform the
epidemiological follow-up of a cohort of 6284 persons treated for
growth failure with pituitary-derived human growth hormone
(hGH)distributed by the National Hormone and Pituitary Program (NHPP).
The primary purpose of this contract is to monitor the magnitude of
CJD occurrence among the NHPP hGH recipients by identification of
deaths by periodic searches of the National Death Index combined with
investigation of these deaths through reviews of medical records, death
certificates and brain pathology. Only written requests for copies of
the solicitation will be honored and may be faxed to (404) 842-6727 or
E-Mailed to BAS4@CDC.GOV. Telephone requests will not be accepted. The
date specified for receipt of offers will be approximately 30 days
after the RFP issue date. Requests for the RFP must specify the RFP No.
200-97-0620(P). All responsible sources that meet the above
requirements may submit a proposal which shall be considered by the
Agency. (0092) Loren Data Corp. http://www.ld.com (SYN# 0018 19970404\B-0006.SOL)
B - Special Studies and Analyses - Not R&D Index Page
|
|